Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses and Other Current Liabilities

v3.24.1.1.u2
Accrued Expenses and Other Current Liabilities
 3 Months Ended
Mar. 31, 2024
Accrued Liabilities and Other Liabilities [Abstract]  
Accrued Expenses and Other Current Liabilities Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities as of March 31, 2024 and December 31, 2023 consisted of the following (in thousands): 
  As of
  March 31, 2024 December 31, 2023
Research and development $ 329  $ 352 
Compensation and benefits 752  580 
General and administrative (including asset acquisition related transaction costs) 1,934  830 
Private placement investment transaction costs 2,034  — 
Commercial operations 1,789  1,873 
Lease liability, current 545  537 
Total accrued expenses and other current liabilities $ 7,383  $ 4,172